Royalty Pharma PLC (RPRX)
28.16
+0.28
(+1.00%)
USD |
NASDAQ |
Apr 19, 16:00
28.16
0.00 (0.00%)
After-Hours: 18:51
Royalty Pharma Enterprise Value: 20.91B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 20.91B |
| April 17, 2024 | 20.79B |
| April 16, 2024 | 20.73B |
| April 15, 2024 | 21.08B |
| April 12, 2024 | 21.06B |
| April 11, 2024 | 21.44B |
| April 10, 2024 | 21.61B |
| April 09, 2024 | 21.74B |
| April 08, 2024 | 21.52B |
| April 05, 2024 | 21.50B |
| April 04, 2024 | 21.29B |
| April 03, 2024 | 21.32B |
| April 02, 2024 | 21.61B |
| April 01, 2024 | 21.82B |
| March 28, 2024 | 22.03B |
| March 27, 2024 | 22.06B |
| March 26, 2024 | 21.96B |
| March 25, 2024 | 21.99B |
| March 22, 2024 | 21.98B |
| March 21, 2024 | 22.05B |
| March 20, 2024 | 22.04B |
| March 19, 2024 | 21.94B |
| March 18, 2024 | 21.88B |
| March 15, 2024 | 21.90B |
| March 14, 2024 | 21.79B |
| Date | Value |
|---|---|
| March 13, 2024 | 21.81B |
| March 12, 2024 | 22.02B |
| March 11, 2024 | 21.90B |
| March 08, 2024 | 22.03B |
| March 07, 2024 | 21.88B |
| March 06, 2024 | 21.74B |
| March 05, 2024 | 21.61B |
| March 04, 2024 | 21.81B |
| March 01, 2024 | 21.83B |
| February 29, 2024 | 22.01B |
| February 28, 2024 | 22.13B |
| February 27, 2024 | 22.44B |
| February 26, 2024 | 22.45B |
| February 23, 2024 | 22.32B |
| February 22, 2024 | 22.32B |
| February 21, 2024 | 22.41B |
| February 20, 2024 | 21.99B |
| February 16, 2024 | 21.82B |
| February 15, 2024 | 21.87B |
| February 14, 2024 | 21.55B |
| February 13, 2024 | 21.55B |
| February 12, 2024 | 21.44B |
| February 09, 2024 | 21.53B |
| February 08, 2024 | 21.28B |
| February 07, 2024 | 21.56B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.54B
Minimum
Sep 21 2023
28.75B
Maximum
Jan 26 2021
24.48B
Average
24.86B
Median
Enterprise Value Benchmarks
| Viatris Inc | 30.13B |
| Walgreens Boots Alliance Inc | 25.86B |
| Pacira BioSciences Inc | 1.458B |
| Amphastar Pharmaceuticals Inc | 2.191B |
| Maravai LifeSciences Holdings Inc | 1.328B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 494.34M |
| Revenue (Quarterly) | 596.07M |
| Total Expenses (Quarterly) | -16.83M |
| EPS Diluted (Quarterly) | 1.10 |
| Profit Margin (Quarterly) | 82.93% |
| Earnings Yield | 8.95% |
| Operating Earnings Yield | 8.79% |
| Normalized Earnings Yield | 7.085 |